AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.5409
-0.0531 (-8.94%)
At close: Apr 2, 2025, 4:00 PM
0.5200
-0.0209 (-3.86%)
After-hours: Apr 2, 2025, 5:56 PM EST
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
5.70M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
AEON News
- 6 days ago - AEON Biopharma Announces CEO Transition - GlobeNewsWire
- 9 days ago - AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - AEON Biopharma, Inc. Announces Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 3 months ago - AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - GlobeNewsWire
- 3 months ago - AEON Biopharma, Inc. Announces Launch of Proposed Public Offering - GlobeNewsWire
- 5 months ago - AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire